NBIXNeurocrine BiosciencesHealth Care
$158.30EarningsJul 29, 2026
1D—1W—1M—3M—1Y—
Market cap$16.4BCompany infoRevenue$3.1B52-wk range$123 – $177IndustryBiotechnologyWebsiteneurocrine.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +23.5% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E24.4×4953
20
862
P / S5.3×2631
4
9
P / FCF19.7×4951
16
90
EV / EBITDA17.5×3637
14
193
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin98.2%9997
98%
99%
Operating margin25.2%7678
5%
26%
Net margin21.6%8285
1%
42%
ROE22.4%7175
1%
34%
ROIC14.6%7367
3%
16%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.128472
0.0
0.3
Net debt / EBITDA-1.0×8377
Current ratio2.938269
Interest coverage999.0×9695
Per shareTTM, with year-over-year change
Revenue / share$30.00▲ +29%
EPS (diluted)$6.49▲ +120%
FCF / share$8.04▲ +69%
Est. EPS growth (fwd)—